Putting It in Perspective Using Medications for Chronic Weight Management. Donna H. Ryan, MD Pennington Biomedical Research Center

Similar documents
ACHIEVING HEALTH: AGENDA: Achieving Health: A Look at Your Weight Management Options

Anti-Obesity Agents Drug Class Prior Authorization Protocol

An Individualized Approach to Optimize Obesity Treatment Louis Aronne, MD

WEIGHT LOSS/MANAGEMENT IS IT JUST ANOTHER PIPE DREAM?

2. Is the request for Alli, Xenical or Belviq? Y N. 3. Has the patient received 6 months or more of therapy? Y N

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

What is obesity? OBESITY. Obesity is a health issue in which someone has so much extra fat that it negatively impacts their health.

Obesity Pharmacotherapy: Options and Applications in Clinical Practice. Scott Kahan, MD, MPH

FDA approves Belviq to treat some overweight or obese adults

Losing weight (and keeping it off) calls for changes to how you live your life, as well as to your connection to food and exercise.

Medical Management of Obesity: Multidisciplinary Team and Pharmacologic Therapy. Shelby Sullivan University of Colorado School Of Medicine

Understanding Obesity: The Causes, Effects, and Treatment Options

WHAT S THE SKINNY ON WEIGHT LOSS MEDICATION SAFETY? January 25, 2019 Pennsylvania Pharmacists Association

Where are We Now? Editor s Note: Who Qualifi es for Obesity Medications?

MEDICAL MANAGEMENT 101

Treating Patients with PRE- DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background

The US FDA, EMA and our TGA use these cutpoints in assessing drug efficacy. Disclosures: Professor John B Dixon

What Are the Effects of Weight Management Pharmacotherapy on Lipid Metabolism and Lipid Levels?

Update on the Recent Advances in Obesity Management. Benjamin O Donnell, MD Oct 5 th, 2018

When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity

Overview of Management of Obesity

Disclosures. Start the Conversation. Agenda. Behavioral and Medical Approaches for Obesity Treatment 10/18/2014

APhA March 2016 Annual Meeting Obesity Cases

Obesity: The Role of Pharmacotherapy The Annual Women s & Children s Health Update Saturday 17th February 2018 Benefits of modest weight loss 3-10%

Cravings are one of the main reasons diets fail

9 out of 10 people struggle with food cravings while dieting?

9 out of 10 people struggle with food cravings while dieting?

Managing Obesity as a Disease. Disclosure. Objectives

Without Background for printing as Pocket Reference

Treating Obesity- NOT Just with Surgery

Management of obesity

Realistic Expectations: Drugs in the Treatment of Obesity. Lora Cotton, D.O. January 20, 2013

HEALTH TRANSITIONS CLINC: PART 1: Weight, Diet and Exercise History

The New Trend of Anti-Obesity Drug

Faculty Disclosures. Vera Tarman, MD, Author:

Insurance Questions for Medical Weight Loss

Understanding. Obesity. An educational resource provided by the Obesity Action Coalition

Weight History. General Patient Questions. Reason for Visit

Clinical Policy: Weight Loss Reference Number: CP.CPA.197 Effective Date: Last Review Date: Line of Business: Commercial

Special Report: The Miracle Supplement For Weight Loss And Optimum Health! By Joel Kaye, MA

Name (Last Name, First Name): SSN #: Date of Birth: Age: Sex: M F Other. Address: Home phone: Work phone: Cell phone:

Lorcaserin (Belviq ) Rimonabant 2008 Sibutramine (Reductil, ) (World Health organization, WHO) 1996 WHO Orlistat (Xenical, )

Overview of the Pharmacologic & Surgical Treatment for Obesity

Let s s start with a case study.

Obesity Management in Type 2 Diabetes

Clinical Policy: Weight Loss Reference Number: CP.CPA.200 Effective Date: Last Review Date: Line of Business: Commercial - HNCA

System): Rapid-Acting Inhaled Insulin for the Treatment of Diabetes

Healthy weight 18.5 to <25. Diabetes Dispatch. Overweight 25 to <30. Obese class I 30 to <35. Obese class II 35 to <40

PHENTERMINE B12 LIPOTROPIC INJECTIONS

PHENTERMINE INFORMATION SHEET

Donna H Ryan, MD, FACP Pennington Biomedical Research Center Baton Rouge, LA.

REFERENCE CODE GDHC282DFR PUBLICATION DATE OCTOBER 2013 BELVIQ (OBESITY) - FORECAST AND MARKET ANALYSIS TO 2022

Clinical Nutrition Center

For Asian individuals the BMI numbers are 27.5 and 25 respectively These values are from the NICE guidelines of 2014

Modest weight loss of 5% to 10%

Monthly WellPATH Spotlight November 2016: Diabetes

Some college. Native American/ Other. 4-year degree 13% Grad work

OBESITY. Caroline Steinman DO

Treatment of Obesity: Diets, Drugs and Surgery

Approaches to Prevention and Management of Obesity Maj Sarah Kelly USAF

Learning Objectives. Currently Available Options. Update on Weight Loss Pharmacotherapy. Dan Bessesen, MD

Using New Guidelines to Improve Best Practices in Obesity Management

Patient Packet. SSM Health Dean Medical Group Weight Management Services 1313 Fish Hatchery Road Madison, WI 53715

Approximately one third of the 15.7 million Americans who are estimated to have diabetes

Chapter 13 Weight Loss: A Healthy Lifestyle Side Effect

The prevalence of obesity in adults has doubled over the past 30 years

Am I at Risk for Type 2 Diabetes?

Syllabi/Slides for this program are a supplement to the live CME session and are not intended for other purposes.

I. ALL CLAIMS: HEALTH CARE PROFESSIONALS

Faculty/Presenter Disclosure

DOCTOR PRESCRIBED DIET PILLS PHENTERMINE 375 MG

Complete the Qsymia Healthcare Provider Training Program in 2 easy steps:

AACE/ACE ALGORITHM FOR THE MEDICAL CARE OF PATIENTS WITH OBESITY

Making Changes: Cognitive Behavior Therapy for Binge Eating Disorder. Michele Laliberte, Ph.D., C.Psych.

Controversies in Obesity Management Public Meeting

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

What s the Skinny?: An Update on Medications for Weight Management

Reduce hunger and help control cravings with CONTRAVE

Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications.

Am I at Risk for Type 2 Diabetes?

Prediabetes 101. What is it and what can I do about it? Intermountainhealthcare.org/diabetes

Update on Treating Obesity: A Multidisciplinary Approach. Marie Harkins, FNP BC, CDE Cayuga Center for Healthy Living

pennsylvania DEPARTMENT OF HUMAN SERVICES

Behavioral Modification and Lorcaserin Second Study for Obesity Management

For Personal Use Only. Any commercial use is strictly prohibited. Role of glucagon-like peptide 1 receptor agonists in management of obesity

DEKALB WOMEN S SPECIALISTS 5295 HWY 78 STE. N STONE MOUNTAIN, GA

Specific treatment for obesity will be determined by your health care provider based on:

The ABCDs of Obesity

Tackling Obesity with Sensitive, Tailored Conversation Foundation. Prepared for: California Nurse Practitioner Conference March 23, 2014

Client Information for Informed Consent FEMINIZING MEDICATIONS FOR TRANSGENDER CLIENTS

Obesity the global epidemic

Please complete and return this form to be considered for evaluation

Welcome to our Center! We are so glad you have chosen our center to assist you with your weight loss goals!

The TRUE Guide to Diabetes Care

Should I Stand Watch?

The Treatment of Obesity: Diet and Medication

How to End the Obesity and Diabetes Crisis in America and the World

Navigating the new weight loss medications Jacqueline Jordan Spiegel, MS, PA-C, DFAAPA Associate Professor Midwestern University

Disclosures. Objectives. Impact of Obesity in Primary Care Practice and What To Do About It. Intuitive Surgical. Consultant

Transcription:

Putting It in Perspective Using Medications for Chronic Weight Management Donna H. Ryan, MD Pennington Biomedical Research Center ryandh@pbrc.edu

Why Use Medications? Medications help patients lose more weight when they are trying to diet. Medications can: reduce hunger, improve satisfaction with smaller meals, make patients resist tempting foods or foods they crave or, in the case of Xenical, help reinforce a low fat diet.

Why do we need drugs for weight loss? To help patients better adhere to their dietary plan, To help more patients achieve meaningful weight loss, To produce more weight loss so that health benefits will be greater, and To help patients sustain lost weight.

Why have medications gotten a bad rap? Older medications were not safe. They weren t studied properly! Short-term studies, few patients. We thought we could produce weight loss and the patient would be cured. The science of obesity was not understood. We thought patients just needed to be told to eat less and exercise more and try harder.

How are newer medications evaluated? FDA requires comparison of >2000 patients treated with medication and a similar number on placebo. They evaluate efficacy (average weight loss, percentage who can achieve 5% or more or 10% or more weight loss and improvement in risk factors). They evaluate safety adverse events recorded at every visit, effect on mood recorded at every visit, routing labs and labs of special interest. If the drug passes initial testing a large study (~10,000 people) is conducted testing the effect on heart attack and stroke.

When do patients need medications? Medications can help patients who need to lose weight to improve health; who are struggling to lose weight with lifestyle change; who don t have any contraindications to a particular medication; and who need help maintaining lost weight.

Some important facts about medications for chronic weight management There is no ideal medication. In the right patient, every medication can be a good medication. In the wrong patient, every medication can be a bad medication. Medications don t work in every patient. The medication profile must be matched to the patient profile. They don t work on their own!

Xenical or Alli -otc (orlistat)

Belviq (lorcaserin)

Qsymia (phentermine/topiramate SR)

Contrave (naltrexone SR/bupropion SR)

Saxenda (liraglutide 3.0 mg)

Thank you!

Navigating Medications: Choosing the Options Best for YOU! Christopher D. Still, DO, FACN, FACP

General Principles of Choosing Weight Loss Medications ALL medications will be most effective when used in conjunction with a reduced calorie meal plan and increased physical activity The more you can be accountable, (food and exercise logs, daily weights, frequent follow ups*,etc), the greater weight loss. Not every medication will work on every patient Need to have REALISTIC expectations I have lost 35 pounds and hit a plateau I ve developed a tolerance to my medication and it doesn t work anymore

Phentermine/Topiramate ER (Qsymia) May help migraine headaches or chronic pain Produced most weight loss of all medications approved Has been used with patients with depression Pregnancy fetal toxicity Glaucoma HYPERthyroidism Uncontrolled blood pressure Heart problems (arrhythmias, etc) Capsules taken daily Produces ~ 12% weight loss after 1 year

Lorcaserin (Belviq) Well tolerated; few side effects May help blood sugar control Should not increase blood pressure Caution with depression medications like fluoxetine (Prozac), paroxetine (Paxil), etc Tablet taken twice daily Produces ~7% weight loss after 1 year

Naltrexone SR/Bupropion SR (Contrave) Smoker Alcohol use Seizure disorder Uncontrolled blood pressure Opioid use oxycodone Tablets taken twice daily Produces ~ 9% weight loss at 1 year

Liraglutide 3.0 mg Diabetic Injected daily Produces ~ 9% weight loss ay 1 year History of pancreatitis Thyroid cancer Kidney probles

Odds of Reducing Body Weight by % Categories at 1 Year with Adjunctive Medication Among those who Complete Treatment* % 100.00 90.00 80.00 70.00 60.00 50.00 40.00 30.00 20.00 10.00 0.00 5% weight loss 10% weight loss *combined with lifestyle modification

Recap Do you have history of glaucoma? Qsymia and Contrave aren t the best choice for you Do you have kidney stones? Avoid Qsymia Do you or a family member have thyroid cancer? Saxsenda is not for you Do you take an SSRI for depression? Qysmia has been used in that patient population Do you need better blood sugar control? Saxsenda and Belviq would be your best option Do you have insurance coverage? NO? Contrave has special pricing

Understanding My Surgical Options Walter Medlin, MD, FACS

Indications for procedure BMI controversial, but still mostly used >27 with Diabetes, Asian, Indian, Native American >30 with any comorbidity (related problem) DO NOT ASSUME THAT you don t have any until evaluated with exam, labs, sleep study, endoscopy DO NOT ASSUME THAT BMI of 35 is medically required, but still many insurance limits (not Medicaid, few others) Self pay = your & MD call

Considerations, Tradeoffs Your tolerance for risk vs uncertainty Money yours or insurance? Diabetes Hiatal Hernia/GERD Weight requirement esp. for knee arthritis Pregnancy plans Mission/overseas work or extended life